Sitravatinib plasma concentrations.
At predose, 30 min, 4 h and 15 days after the first sitravatinib monotherapy dose, as well as 4 weeks following the addition of nivolumab (day 43). Reported are mean values with error bars indicating standard deviation. D day. Source data are provided in the Source Data file.